Advisornet Financial’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-375
| Closed | -$2.04K | – | 2213 |
|
2024
Q4 | $2.04K | Hold |
375
| – | – | ﹤0.01% | 1599 |
|
2024
Q3 | $2.71K | Buy |
+375
| New | +$2.71K | ﹤0.01% | 1688 |
|
2024
Q1 | – | Sell |
-2
| Closed | -$43 | – | 2432 |
|
2023
Q4 | $43 | Sell |
2
-3
| -60% | -$65 | ﹤0.01% | 2399 |
|
2023
Q3 | $103 | Sell |
5
-1
| -17% | -$21 | ﹤0.01% | 2209 |
|
2023
Q2 | $282 | Buy |
6
+1
| +20% | +$47 | ﹤0.01% | 2159 |
|
2023
Q1 | $210 | Buy |
5
+1
| +25% | +$42 | ﹤0.01% | 2245 |
|
2022
Q4 | $153 | Buy |
+4
| New | +$153 | ﹤0.01% | 2239 |
|
2021
Q4 | – | Sell |
-310
| Closed | -$14K | – | 2119 |
|
2021
Q3 | $14K | Sell |
310
-18
| -5% | -$813 | ﹤0.01% | 1358 |
|
2021
Q2 | $19K | Buy |
328
+18
| +6% | +$1.04K | ﹤0.01% | 1233 |
|
2021
Q1 | $23K | Sell |
310
-90
| -23% | -$6.68K | ﹤0.01% | 1148 |
|
2020
Q4 | $35K | Buy |
+400
| New | +$35K | ﹤0.01% | 972 |
|
2020
Q1 | – | Sell |
-160
| Closed | -$12K | – | 1905 |
|
2019
Q4 | $12K | Buy |
+160
| New | +$12K | ﹤0.01% | 1345 |
|